03 Profile
Hansard to 4 November 2026 · 31,174 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Academic · Dementia
Benedikt Berninger
King's College London
press citation on 1 topic since 26 Aug 2026 · last quoted 26 Aug 2026
02 Quoted on · 1 of 29 topics
Benedikt Berninger: key facts
- Kind of voice
- Academic
- Role
- King's College London
- Quoted on
- Dementia
- Tracked press citations
- 1
- Most recently quoted
- 26 Aug 2026
04 The signal · where Benedikt Berninger sits on dementia
Ranked 78= of 462 voices quoted in the press on dementia, level with 384 others on 1 citation.
Ranked on press citations on this topic only, not across all topics. Joint positions share a rank.
- 1Eric SchmidtAcademicResearch Associate Professor (Laboratory of Molecular Biology); also named as scientific reviewer of ALZinfo.org articles for the Fisher Center for Alzheimer's Research Foundation, The Rockefeller University (New York); reviewer credit given as Fisher Center for Alzheimer's Research Foundation at The Rockefeller University10
- 2Hilary Evans-Newton CBESector leaderChief Executive, Alzheimer's Research UK8
- 3Prof Jonathan SchottAcademicProfessor of Neurology, Dementia Research Centre; Chief Medical Officer, Alzheimer's Research UK, UCL Queen Square Institute of Neurology7
- 78=Susanne HernesAcademicLeader of the REACT MCI study at the University of Oslo1
- 78=András LakatosAcademicUniversity of Cambridge1
- 78=Benedikt BerningerAcademicKing's College London1
- 78=Peisheng XuAcademicUniversity of South Carolina1
- 78=Professor Arshad RatherClinicianconsultant geriatrician at Medical Express Clinic1
Showing the leaders and the ranks around 78=, of 462 voices · See every voice on the topic →
05 On the record · press
What Benedikt Berninger has said
- newscientist.com1
Where Benedikt Berninger has been quoted
- 01Nanoparticles ease Alzheimer’s by making neurons from other cellsnewscientist.com · 26 Aug 2026
Verbatim
“We need to check [whether] these neurons [would] be beneficial, rather than screwing up the network... It "could have an enormous effect on the treatment of many brain diseases", including schizophrenia, motor neuron disease (such as ALS) and Parkinson's disease”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.